However, in between the 12 months, the SP should still be moving positively. Not retracing back to CR price at .038c or lower whilst we wait for that catalyst.
The announcements need to sell the stock. Not breadcrumb people into information.
Announce the CLIA waiver study has begun, announce substantial purchase orders, announce partnerships, announce other product updates outside of Febridx and Viradx.
They do more for other company products than just this. Bugger all has been said about FFN since phase 1 was obtained and the $10Million received.
They should also push this locally more than they are given this is the market they are listed in.
However, in between the 12 months, the SP should still be moving...
Add to My Watchlist
What is My Watchlist?
